Results · Apr-Jun 2026 · filed 3 Aug 2026
Borosil Scientific Q1 FY27 results
Sales grew 11% to ₹107 crore from ₹96 crore in Apr-Jun 2025.
Operating profit grew 74% to ₹8.5 crore, an operating margin of 7.9% (up 2.8 points from a year ago).
Net profit turned positive: ₹4.4 crore against a loss of ₹4.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −25%, net profit −84%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 106.8 | 96.0 | +11% |
| Operating profit (EBITDA) | 8.5 | 4.9 | +74% |
| Operating margin | 7.9% | 5.1% | +2.8 pts |
| Net profit | 4.4 | -4.2 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 3 Aug 2026Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026
- 3 Aug 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On August 03, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.